The US FDA had inspected Aurobindo's Unit-7 between January 28 and February 10, 2026. The inspection observations pointed to ...
By binding to both vaccine antibodies and a protein frequently upregulated in tumors, a molecular bridge harnesses antiviral immunity to fight cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results